SOURCE: Sequiam Biometrics, Inc.

September 10, 2007 10:30 ET

Intel Industry Veteran Joins Sequiam Corporation Board of Directors

ORLANDO, FL--(Marketwire - September 10, 2007) - Sequiam Corporation (OTCBB: SQUM), a leading provider of innovative consumer lifestyle biometric technologies and services, announced today that Intel's Jake Smith has joined its Board of Directors. Jake will also chair the company's Audit Committee and will serve on its Governance and Compensation Committee.

Nick VandenBrekel, Chief Executive Officer and Chairman of Sequiam, said, "Jake is a technology veteran whose experience in developing, organizing and launching next generation technology products for the consumer and enterprise segments will serve Sequiam well. His extensive background in managing dynamic growth environments from the data center to next-generation mobile computing devices will serve our shareholders, customers and employees well into the future."

Jake Smith said, "Biometrics is a fast growing and fascinating technology that has the potential to transform the way humanity lives, works and plays in a global economy. Sequiam, Nick VandenBrekel and his dedicated staff around the world have developed a platform to deliver low-cost high-volume biometric products for the world economy. There is no easy way to achieve this goal quickly but innovation will be at the heart of the company's growth. I look forward to the opportunity to contribute my experience, deliver shareholder value and learn from Sequiam's innovators."

Jake Smith is currently a member of Intel Server Products Group helping lead Intel's virtualization efforts. Prior to his current role, Jake helped lead the launch of Intel's Mobile Processors for both notebooks and handheld computing products. Before Intel, Jake held management and product development roles with IBM and Sequent Computer Systems.

About Sequiam

Headquartered in Orlando, Florida, Sequiam Corporation develops, markets, and supports a portfolio of highly robust proprietary biometrically enabled consumer lifestyle and commercial products and OEM solutions. In addition, Sequiam has invested heavily in research and development to develop unique products and solutions for the biometric industry worldwide. Sequiam's biometric solutions incorporate low-cost, high-volume manufacturing processes targeted at the consumer and commercial market. Sequiam is a global company with offices in Taiwan, China, and South Africa. For more information, please visit http://www.sequiam.com.

Safe Harbor Statement -- Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the company and its subsidiaries. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by the company may differ materially from these statements due to a number of factors. Any forward-looking statements speak only as of the date made. Statements made in this document that are not purely historical are forward-looking statements, including any statements as to beliefs, plans, expectations, or intentions regarding the future. Risk factors that may cause results to differ from projections include, without limitation, loss of suppliers, loss of customers, inadequate capital, competition, loss of key executives, declining prices, and other economic factors. The company assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. You should independently investigate and fully understand all risks before making investment decisions. Additional factors can be found in our annual report on form 10-KSB for the fiscal year ended December 31, 2006, and our other filings with the SEC which are available at the SEC's Internet site (www.sec.gov). Forward-looking statements in this press release speak only as of the date of this press release, and we assume no obligation to update forward-looking statements or the reasons why actual results could differ.

Contact Information